Aurobindo Pharma consolidated net profit rises 25.20% in the June 2026 quarter
(06 Aug 2026)

Back
Net profit of Aurobindo Pharma rose 25.20% to Rs 1032.56 crore in the quarter ended June 2026 as against Rs 824.75 crore during the previous quarter ended June 2025. Sales rose 16.86% to Rs 9105.82 crore in the quarter ended June 2026 as against Rs 7791.77 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales9105.827791.77 17
OPM %20.6420.57 -
PBDT2042.091612.50 27
PBT1555.271206.80 29
NP1032.56824.75 25

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew